Studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats

博士 === 國立臺灣大學 === 毒理學研究所 === 94 === Both carbendazim and benomyl are antifungal benzimidazole compounds used to control fungal proliferation on a large variety of crops. The study was conducted to study the possible mechanism of reproductive and developmental toxicity induced by carbendazim and its...

Full description

Bibliographic Details
Main Authors: Shui-Yuan Lu, 呂水淵
Other Authors: 翁祖輝
Format: Others
Language:zh-TW
Published: 2006
Online Access:http://ndltd.ncl.edu.tw/handle/05234796319259037339
id ndltd-TW-094NTU05229008
record_format oai_dc
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 博士 === 國立臺灣大學 === 毒理學研究所 === 94 === Both carbendazim and benomyl are antifungal benzimidazole compounds used to control fungal proliferation on a large variety of crops. The study was conducted to study the possible mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats. Treatment with low and middle doses of carbendazim decreased the absolute and relative testis weights, while high doses increased the testis weight more than that of middle dose due to inflammation. Carbendazim also decreased the absolute and relative weights of the epididymis in a dose-dependent manner. In a addition, carbendazim increased the lesion index of testis and epididymis, and decreased sperm motility and concentration of cauda epididymis in a dose-dependent manner. Benomyl exerted the same effect on the male rat as previously described for carbendazim. Carbendazim replaced binding of [3H]-5α-dihydrotestosterone to androgen receptors (AR) of testis extract from untreated rats in a concentration-dependent manner in vitro. Treatment of male rats with carbendazim for 56 d produced dose-dependent increases of androgen receptor concentrations in testis and epididymis. Therefore, there was a high correlation between reduction of testis and epididymis weights, decrease in sperm quality, and increase in the lesion index and androgen receptor concentration in male rats. Co-treatment of male rats with carbendazim and flutamide once daily for 28d prevented the decrease of testis weight induced by treatment with carbendazim alone. In addition, the co-treatment prevented losses of spermatozoa and in cell morphology and the decrease of sperm concentration induced by carbendazim. Treatment with carbendazim increased the expressions of AR mRNA and protein of rat testis while flutamide decreased the same expressions. Co-treatment with carbendazim and flutamide decreased the expressions of AR mRNA and protein of rat testis in a dose-dependent manner. Premating treatment of male and female rats with carbendazim for 28 d produced androgenic effects including incomplete development of the uterine horn, enlargement of the uretha, absence of the vagina, and induction of seminal vesicles in female offspring, without marked effects in male offspring. Premating treatment with benomyl resulted in incomplete development of the uterine horn and absence of the vagina in female offspring and produced testis and epididymis atrophy in male offspring. Pregnant female rats were treated with 6.25, 12.5, or 25 mg/kg carbendazim and 0.6, 2.5, or 10 mg/kg flutamide by gavage once daily from day 0 to 20. Another group of rats were treated with 25 and 50 mg/kg benomyl, the parent compound of carbendazim for comparison purposes. In male offspring, 12.5 and 25 mg/kg carbendazim increased anogenital distance (AGD), an androgen-dependent marker, on PND 2. Treatment with benomyl also increased AGD. Cotreatment with 0.6, 2.5, and 10 mg/kg flutamide blocked the androgenic effect on AGD induced by 25 mg/kg carbendazim. The androgenic effects of carbendazim and benomyl on AGD were reversible on PND 22 and later. Carbendazim had no effects on other androgen-dependent markers including testis and epididymis malformations, hypospadias, and organ weights of the seminal vesicle and levator ani bulbocavernosus muscle on PND 56. Surprisingly, carbendazim antagonized the antiandrogenic effects on these markers induced by flutamide cotreatment. In female offspring, carbendazim produced synergistic effects on the flutamide cotreatment-mediated increases of organs weights in liver and kidney on PND 56. Carbenazim had no marked effects on female reproductive organs. These findings show that carbendazim exposure in utero displays a transient and weak androgenic effect and reduces flutamide antiandrogenicity in male rats. The fungicide enhances flutamide-mediated liver and kidney weight increases in female rats. We concluded that AR plays an important role in the reproductive and developmental toxicity in rats.
author2 翁祖輝
author_facet 翁祖輝
Shui-Yuan Lu
呂水淵
author Shui-Yuan Lu
呂水淵
spellingShingle Shui-Yuan Lu
呂水淵
Studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats
author_sort Shui-Yuan Lu
title Studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats
title_short Studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats
title_full Studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats
title_fullStr Studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats
title_full_unstemmed Studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats
title_sort studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats
publishDate 2006
url http://ndltd.ncl.edu.tw/handle/05234796319259037339
work_keys_str_mv AT shuiyuanlu studiesonthemechanismofreproductiveanddevelopmentaltoxicityinducedbycarbendazimanditsprecursorbenomylinrats
AT lǚshuǐyuān studiesonthemechanismofreproductiveanddevelopmentaltoxicityinducedbycarbendazimanditsprecursorbenomylinrats
AT shuiyuanlu nóngyàobèifēntìyǔqíqiánqūwùmiǎnlàidéyòufādàshǔshēngzhíyǔfāyùdúxìngzuòyòngjīzhìzhīyánjiū
AT lǚshuǐyuān nóngyàobèifēntìyǔqíqiánqūwùmiǎnlàidéyòufādàshǔshēngzhíyǔfāyùdúxìngzuòyòngjīzhìzhīyánjiū
_version_ 1718150224825810944
spelling ndltd-TW-094NTU052290082015-12-16T04:38:22Z http://ndltd.ncl.edu.tw/handle/05234796319259037339 Studies on the mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats 農藥貝芬替與其前驅物免賴得誘發大鼠生殖與發育毒性作用機制之研究 Shui-Yuan Lu 呂水淵 博士 國立臺灣大學 毒理學研究所 94 Both carbendazim and benomyl are antifungal benzimidazole compounds used to control fungal proliferation on a large variety of crops. The study was conducted to study the possible mechanism of reproductive and developmental toxicity induced by carbendazim and its precursor benomyl in rats. Treatment with low and middle doses of carbendazim decreased the absolute and relative testis weights, while high doses increased the testis weight more than that of middle dose due to inflammation. Carbendazim also decreased the absolute and relative weights of the epididymis in a dose-dependent manner. In a addition, carbendazim increased the lesion index of testis and epididymis, and decreased sperm motility and concentration of cauda epididymis in a dose-dependent manner. Benomyl exerted the same effect on the male rat as previously described for carbendazim. Carbendazim replaced binding of [3H]-5α-dihydrotestosterone to androgen receptors (AR) of testis extract from untreated rats in a concentration-dependent manner in vitro. Treatment of male rats with carbendazim for 56 d produced dose-dependent increases of androgen receptor concentrations in testis and epididymis. Therefore, there was a high correlation between reduction of testis and epididymis weights, decrease in sperm quality, and increase in the lesion index and androgen receptor concentration in male rats. Co-treatment of male rats with carbendazim and flutamide once daily for 28d prevented the decrease of testis weight induced by treatment with carbendazim alone. In addition, the co-treatment prevented losses of spermatozoa and in cell morphology and the decrease of sperm concentration induced by carbendazim. Treatment with carbendazim increased the expressions of AR mRNA and protein of rat testis while flutamide decreased the same expressions. Co-treatment with carbendazim and flutamide decreased the expressions of AR mRNA and protein of rat testis in a dose-dependent manner. Premating treatment of male and female rats with carbendazim for 28 d produced androgenic effects including incomplete development of the uterine horn, enlargement of the uretha, absence of the vagina, and induction of seminal vesicles in female offspring, without marked effects in male offspring. Premating treatment with benomyl resulted in incomplete development of the uterine horn and absence of the vagina in female offspring and produced testis and epididymis atrophy in male offspring. Pregnant female rats were treated with 6.25, 12.5, or 25 mg/kg carbendazim and 0.6, 2.5, or 10 mg/kg flutamide by gavage once daily from day 0 to 20. Another group of rats were treated with 25 and 50 mg/kg benomyl, the parent compound of carbendazim for comparison purposes. In male offspring, 12.5 and 25 mg/kg carbendazim increased anogenital distance (AGD), an androgen-dependent marker, on PND 2. Treatment with benomyl also increased AGD. Cotreatment with 0.6, 2.5, and 10 mg/kg flutamide blocked the androgenic effect on AGD induced by 25 mg/kg carbendazim. The androgenic effects of carbendazim and benomyl on AGD were reversible on PND 22 and later. Carbendazim had no effects on other androgen-dependent markers including testis and epididymis malformations, hypospadias, and organ weights of the seminal vesicle and levator ani bulbocavernosus muscle on PND 56. Surprisingly, carbendazim antagonized the antiandrogenic effects on these markers induced by flutamide cotreatment. In female offspring, carbendazim produced synergistic effects on the flutamide cotreatment-mediated increases of organs weights in liver and kidney on PND 56. Carbenazim had no marked effects on female reproductive organs. These findings show that carbendazim exposure in utero displays a transient and weak androgenic effect and reduces flutamide antiandrogenicity in male rats. The fungicide enhances flutamide-mediated liver and kidney weight increases in female rats. We concluded that AR plays an important role in the reproductive and developmental toxicity in rats. 翁祖輝 2006 學位論文 ; thesis 155 zh-TW